<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalSubTitle>An Official Journal of the American Association of Pharmaceutical Scientists</JournalSubTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCB" Type="Primary">Biomedicine</JournalSubject>
        <JournalSubject Code="SCB21007" Priority="1" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="SCL14005" Priority="2" Type="Secondary">Biochemistry, general</JournalSubject>
        <JournalSubject Code="SCC12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
        <JournalSubject Code="SCF00008" Priority="4" Type="Secondary">Pharmacy</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <OnlineDate>
              <Year>2005</Year>
              <Month>10</Month>
              <Day>19</Day>
            </OnlineDate>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art9">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73579</ArticleID>
            <ArticleDOI>10.1208/aapsj070359</ArticleDOI>
            <ArticleSequenceNumber>9</ArticleSequenceNumber>
            <ArticleTitle Language="En">RETRACTED ARTICLE: Recent advances for the treatment of cocaine abuse: Central nervous system immunopharmacotherapy</ArticleTitle>
            <ArticleFirstPage>E579</ArticleFirstPage>
            <ArticleLastPage>E586</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>1</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>4</Month>
                <Day>7</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>30</Day>
              </Accepted>
              <OnlineDate>
                <Year>2005</Year>
                <Month>10</Month>
                <Day>19</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1 Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tobin</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Dickerson</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1 Aff2" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Kim</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Janda</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(858) 784-2516</Phone>
                  <Fax>(858) 784-2595</Fax>
                  <Email>kdjanda@scripps.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>The Skaggs Institute for Chemical Biology and Department of Chemistry</OrgDivision>
                <OrgName>The Scripps Research Institute</OrgName>
                <OrgAddress>
                  <Street>10550 North Torry Pines Road</Street>
                  <Postcode>92037</Postcode>
                  <City>La Jolla</City>
                  <State>CA</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Department of Immunology</OrgDivision>
                <OrgName>The Scripps Research Institute</OrgName>
                <OrgAddress>
                  <Street>10550 North Torry Pines Road</Street>
                  <Postcode>92037</Postcode>
                  <City>La Jolla</City>
                  <State>CA</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Cocaine addiction continues to be a major health and societal problem in spite of governmental efforts devoted toward educating the public of the dangers of illicit drug use. A variety of pharmacotherapies and psychosocial programs have been proposed in an effort to provide a method for alleviation of the physical and psychological symptoms of cocaine abuse. Unfortunately, these methods have been met with limited success, illustrating a critical need for new effective approaches for the treatment of cocaine addiction. Recently an alternative cocaine abuse treatment strategy was proposed using intranasal administration of an engineered filamentous bacteriophage displaying cocaine-sequestering antibodies on its surface. These phage particles are an effective vector for CNS penetration and are capable of binding cocaine, thereby blocking its behavioral effects in a rodent model. The convergence of phage display and immunopharmacotherapy has allowed for an investigation of the efficacy of protein-based therapeutics acting within the CNS on the effects of cocaine in animal models and has uncovered a new tool in the battle against cocaine addiction.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>cocaine</Keyword>
              <Keyword>central nervous system</Keyword>
              <Keyword>immunopharmacotherapy</Keyword>
              <Keyword>virus</Keyword>
              <Keyword>phage display</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 19, 2005</SimplePara>
            </ArticleNote>
            <ArticleNote Type="Misc">
              <SimplePara>A retraction note to this article is available at <ExternalRef>
                  <RefSource>http://dx.doi.org/10.1208/s12248-012-9365-2</RefSource>
                  <RefTarget Address="10.1208/s12248-012-9365-2" TargetType="DOI"/>
                </ExternalRef>.</SimplePara>
            </ArticleNote>
            <ArticleNote Type="Misc">
              <SimplePara Type="Important">This article has been retracted because of a substantial degree of
duplication with "Bacteriophage-mediated protein delivery into the central nervous system and its
application in immunopharmacotherapy. Expert Opin Biol Ther. 2005 Jun;5(6) 773–781."</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73579.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Neurobiology of addiction. Toward the development of new therapies</ArticleTitle>
                  <JournalTitle>Ann NY Acad Sci.</JournalTitle>
                  <VolumeID>909</VolumeID>
                  <FirstPage>170</FirstPage>
                  <LastPage>185</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10911930</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1749-6632.2000.tb06682.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlsVOjtb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Koob GF. Neurobiology of addiction. Toward the development of new therapies.<Emphasis Type="Italic">Ann NY Acad Sci.</Emphasis> 2000;909:170–185.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Weiss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Drug addiction: functional neurotoxicity of the brain reward systems</ArticleTitle>
                  <JournalTitle>Neurotoxic Res.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>145</FirstPage>
                  <LastPage>156</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF03033235</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjs12iurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weiss F., Koob GF. Drug addiction: functional neurotoxicity of the brain reward systems.<Emphasis Type="Italic">Neurotoxic Res.</Emphasis> 2001;3:145–156.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>Melichar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MRC</Initials>
                    <FamilyName>Daglish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Nutt</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Addiction and withdrawalcurrent views</ArticleTitle>
                  <JournalTitle>Curr Opin Pharmacol.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>90</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11712541</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1471-4892(01)00011-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXis1Oltr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Melichar JK, Daglish MRC, Nutt DJ. Addiction and withdrawalcurrent views.<Emphasis Type="Italic">Curr Opin Pharmacol.</Emphasis> 2001;1:84–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Spanagel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Weiss</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The dopamine hypothesis of reward: past and current status</ArticleTitle>
                  <JournalTitle>Trends Neurosci.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>521</FirstPage>
                  <LastPage>527</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10529820</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0166-2236(99)01447-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmvVKhtrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status.<Emphasis Type="Italic">Trends Neurosci.</Emphasis> 1999;22:521–527.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Chiana</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The role of dopamine in drug abuse viewed from the perspective of its role in motivation</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend.</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>95</FirstPage>
                  <LastPage>137</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0376-8716(95)01118-I</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Di Chiana G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 1995;38:95–137.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C-E</Initials>
                    <FamilyName>Johanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Fischman</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">The pharmacology of cocaine related to its abuse</ArticleTitle>
                  <JournalTitle>Pharmacol Rev.</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>52</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2682679</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXmtVymurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Johanson C-E, Fischman MW. The pharmacology of cocaine related to its abuse.<Emphasis Type="Italic">Pharmacol Rev.</Emphasis> 1989;41:3–52.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Blaine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Ling</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Psychopharm acologic treatment of cocaine dependence</ArticleTitle>
                  <JournalTitle>Psychopharmacol Bull.</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>11</FirstPage>
                  <LastPage>14</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1609036</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK38zgt1ersw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Blaine JD, Ling W. Psychopharm acologic treatment of cocaine dependence.<Emphasis Type="Italic">Psychopharmacol Bull.</Emphasis> 1992;28:11–14.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibBook>
                  <InstitutionalAuthorName>Substance Abuse and Mental Health Services Administration, Office of Applied Studies</InstitutionalAuthorName>
                  <Year>1993</Year>
                  <BookTitle>Preliminary estimates from the 1992 Household Survey on Drug Abuse</BookTitle>
                  <SeriesTitle Language="En">Advance Report</SeriesTitle>
                  <NumberInSeries>No. 3</NumberInSeries>
                  <PublisherName>US Department of Health and Human Services, Public Health Service</PublisherName>
                  <PublisherLocation>Washington, DC</PublisherLocation>
                </BibBook>
                <BibUnstructured>Substance Abuse and Mental Health Services Administration, Office of Applied Studies,<Emphasis Type="Italic">Preliminary estimates from the 1992 Household Survey on Drug Abuse</Emphasis>.<Emphasis Type="Italic">Advance Report No. 3</Emphasis>. Washington, DC: US Department of Health and Human Services, Public Health Service, June 1993.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LL</Initials>
                    <FamilyName>Cregler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Herbert</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Medical complications of cocaine abuse</ArticleTitle>
                  <JournalTitle>N Engl J Med.</JournalTitle>
                  <VolumeID>315</VolumeID>
                  <FirstPage>1495</FirstPage>
                  <LastPage>1500</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3537786</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM198612043152327</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2s%2FmsV2jtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cregler LL, Herbert M. Medical complications of cocaine abuse.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1986;315:1495–1500.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Jarlais</FamilyName>
                    <Particle>Des</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Friedman</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">AIDS and i.v. drug use</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>245</VolumeID>
                  <FirstPage>578</FirstPage>
                  <LastPage>579</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2762809</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.2762809</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Des Jarlais DC, Friedman SR. AIDS and i.v. drug use.<Emphasis Type="Italic">Science.</Emphasis> 1989;245:578–579.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ChapterTitle Language="En">Substaance abuse in adulthood</ChapterTitle>
                  <BibEditorName>
                    <Initials>G</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>D</Initials>
                    <FamilyName>Woolf</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Substance Abuse: Pharmacologic, Developmental and Clinical Perspectives</BookTitle>
                  <PublisherName>Delman Publishing</PublisherName>
                  <PublisherLocation>Albany</PublisherLocation>
                  <FirstPage>157</FirstPage>
                  <LastPage>170</LastPage>
                </BibChapter>
                <BibUnstructured>Lee JH, Bennett G. Substaance abuse in adulthood. In: Bennett G, Woolf D, ed.<Emphasis Type="Italic">Substance Abuse: Pharmacologic, Developmental and Clinical Perspectives</Emphasis>. Albany: Delman Publishing, 1991:157–170.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Walsh</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ChapterTitle Language="En">Behavioral pharmacology of cocaine</ChapterTitle>
                  <BibEditorName>
                    <Initials>RE</Initials>
                    <FamilyName>Tarter</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>RT</Initials>
                    <FamilyName>Ammerman</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Ott</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Handbook of Substance Abuse: Neurobehavioral Pharmacology</BookTitle>
                  <PublisherName>Plenum</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>187</FirstPage>
                  <LastPage>200</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/978-1-4757-2913-9_12</Handle>
                  </Occurrence>
                </BibChapter>
                <BibUnstructured>Walsh SL. Behavioral pharmacology of cocaine. In: Tarter RE, Ammerman RT, Ott PJ, eds.<Emphasis Type="Italic">Handbook of Substance Abuse: Neurobehavioral Pharmacology</Emphasis>: New York: Plenum; 1998:187–200.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Mendelson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Mello</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Management of cocaine abuse and dependence</ArticleTitle>
                  <JournalTitle>N Engl J Med.</JournalTitle>
                  <VolumeID>334</VolumeID>
                  <FirstPage>965</FirstPage>
                  <LastPage>972</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8596599</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM199604113341507</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XislKmsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mendelson JH, Mello NK. Management of cocaine abuse and dependence.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1996;334:965–972.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Gorelick</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ChapterTitle Language="En">Pharmacologic interventions for cocaine, crack, and other stimulant addiction</ChapterTitle>
                  <BibEditorName>
                    <Initials>AW</Initials>
                    <FamilyName>Graham</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>TK</Initials>
                    <FamilyName>Schultz</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Principles of Addiction Medicine</BookTitle>
                  <PublisherName>American Society of Addiction Medicine</PublisherName>
                  <PublisherLocation>Chevy Chase, MD</PublisherLocation>
                  <FirstPage>89</FirstPage>
                  <LastPage>111</LastPage>
                </BibChapter>
                <BibUnstructured>Gorelick DA. Pharmacologic interventions for cocaine, crack, and other stimulant addiction. In: Graham AW, Schultz TK, eds.,<Emphasis Type="Italic">Principles of Addiction Medicine</Emphasis>. Chevy Chase, MD. American Society of Addiction Medicine; 2003:89–111.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Gorelick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Gardner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z-X</Initials>
                    <FamilyName>Xi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Agents in the development for the management of cocaine abuse</ArticleTitle>
                  <JournalTitle>Drugs.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1547</FirstPage>
                  <LastPage>1573</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15233592</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2165/00003495-200464140-00004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntVahtL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gorelick DA, Gardner EL, Xi Z-X. Agents in the development for the management of cocaine abuse.<Emphasis Type="Italic">Drugs.</Emphasis> 2004;64:1547–1573.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DB</Initials>
                    <FamilyName>Leiderman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Shoptaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Montgomery</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Cocaine rapid efficacy screening trial (CREST). A paradigm for the controlled evaluation of candidate medications for cocaine dependence</ArticleTitle>
                  <JournalTitle>Addiction.</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15773068</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1360-0443.2005.00988.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leiderman DB, Shoptaw S, Montgomery A, et al. Cocaine rapid efficacy screening trial (CREST). A paradigm for the controlled evaluation of candidate medications for cocaine dependence.<Emphasis Type="Italic">Addiction.</Emphasis> 2005;100:1–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Winhusen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Somoza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Harrer</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">A placebo-controlled screening trial of tiagabine, sertaline and donepezil as cocaine dependence treatment</ArticleTitle>
                  <JournalTitle>Addiction.</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>68</FirstPage>
                  <LastPage>77</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15730351</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1360-0443.2005.00992.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Winhusen TM, Somoza EC, Harrer JM, et al. A placebo-controlled screening trial of tiagabine, sertaline and donepezil as cocaine dependence treatment.<Emphasis Type="Italic">Addiction.</Emphasis> 2005;100:68–77.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Gonzalez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Sevarino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Sofuoglu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study</ArticleTitle>
                  <JournalTitle>Addiction.</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>1625</FirstPage>
                  <LastPage>1632</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14616189</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1360-0443.2003.00544.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gonzalez G, Sevarino K, Sofuoglu M, et al. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.<Emphasis Type="Italic">Addiction.</Emphasis> 2003;98:1625–1632</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Carroll</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LR</Initials>
                    <FamilyName>Fenton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Ball</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial</ArticleTitle>
                  <JournalTitle>Arch Gen Psychiatry</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>264</FirstPage>
                  <LastPage>272</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14993114</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1001/archpsyc.61.3.264</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXislylur0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis> 2004;61:264–272.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Houtsmuller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LD</Initials>
                    <FamilyName>Notes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Newton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Transdermal selegiline and intravenous cocaine: safety and interactions</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl).</JournalTitle>
                  <VolumeID>172</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14605792</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00213-003-1616-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtlehsr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Houtsmuller EJ, Notes LD, Newton T, et al. Transdermal selegiline and intravenous cocaine: safety and interactions.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 2004;172:31–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Shoptaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Rotheram-Fuller</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use</ArticleTitle>
                  <JournalTitle>J Clin Psychiatry.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1440</FirstPage>
                  <LastPage>1448</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14728105</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4088/JCP.v64n1207</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvFCqsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shoptaw S, Yang X, Rotheram-Fuller EJ, et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.<Emphasis Type="Italic">J Clin Psychiatry.</Emphasis> 2003;64:1440–1448.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Kampman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Pettinati</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KG</Initials>
                    <FamilyName>Lynch</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A pilot trial of topiramate for the treatment of cocaine dependence</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend.</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>233</FirstPage>
                  <LastPage>240</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15283944</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.drugalcdep.2004.03.008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmt1Wksbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kampman KM, Pettinati H, Lynch KG, et al. A pilot trial of topiramate for the treatment of cocaine dependence.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 2004;75:233–240.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Kampman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Volpicelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Mulvaney</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend.</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>69</FirstPage>
                  <LastPage>78</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11297832</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0376-8716(00)00193-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXisF2rsLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kampman KM, Volpicelli JR, Mulvaney F, et al. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 2001;63:69–78.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BD</Initials>
                    <FamilyName>Caudill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Koman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Luckey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Flynn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Hubbard</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure</ArticleTitle>
                  <JournalTitle>J Addict Dis.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>115</FirstPage>
                  <LastPage>128</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7734463</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1300/J069v13n04_01</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M3lt1agug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hoffman JA III, Caudill BD III, Koman JJ III, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure.<Emphasis Type="Italic">J Addict Dis.</Emphasis> 1994;13:115–128.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Cashman</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Biocatalysts in detoxication of drug of abuse</ArticleTitle>
                  <JournalTitle>NIDA Res Monogr.</JournalTitle>
                  <VolumeID>173</VolumeID>
                  <FirstPage>225</FirstPage>
                  <LastPage>258</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9260191</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXntlSltb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cashman JR. Biocatalysts in detoxication of drug of abuse.<Emphasis Type="Italic">NIDA Res Monogr.</Emphasis> 1997;173:225–258.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MRA</Initials>
                    <FamilyName>Carrera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ashley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Parsons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Suppression of psychoactive effects of cocaine by active immunization</ArticleTitle>
                  <JournalTitle>Nature.</JournalTitle>
                  <VolumeID>378</VolumeID>
                  <FirstPage>727</FirstPage>
                  <LastPage>730</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7501020</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/378727a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXhtVSnt7vN</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization.<Emphasis Type="Italic">Nature.</Emphasis> 1995;378:727–730.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MRA</Initials>
                    <FamilyName>Carrera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ashley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>zhou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cocaine vaccines: antibody protection against relapse in a rat model</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>6202</FirstPage>
                  <LastPage>6206</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10823960</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.97.11.6202</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjvFaqs70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carrera MRA, Ashley JA, zhou B, Wirsching P, Koob GF, Janda KD. Cocaine vaccines: antibody protection against relapse in a rat model.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2000;97:6202–6206.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MRA</Initials>
                    <FamilyName>Carrera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ashley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">A second-generation vaccine protects against the psychoactive effects of cocaine</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>1988</FirstPage>
                  <LastPage>1992</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11172063</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.98.4.1988</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhsVWitrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carrera MRA, Ashley JA, Wirsching P, Koob GF, Janda KD. A second-generation vaccine protects against the psychoactive effects of cocaine.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2001;98:1988–1992.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BS</Initials>
                    <FamilyName>Fox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Kantak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Edwards</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Efficacy of a therapeutic cocaine vaccine in rodent models</ArticleTitle>
                  <JournalTitle>Nat Med.</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>11129</FirstPage>
                  <LastPage>11132</LastPage>
<Occurrence Type="DOI">
<Handle>10.1038/nm1096-1129</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Fox BS, Kantak KM, Edwards MA, et al. Efficacy of a therapeutic cocaine vaccine in rodent models.<Emphasis Type="Italic">Nat Med.</Emphasis> 1996;2:11129–11132.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Kantak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EG</Initials>
                    <FamilyName>Lipman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bond</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Giovanoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BS</Initials>
                    <FamilyName>Fox</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl.)</JournalTitle>
                  <VolumeID>148</VolumeID>
                  <FirstPage>251</FirstPage>
                  <LastPage>262</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s002130050049</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXit1ensb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, Fox BS. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.<Emphasis Type="Italic">Psychopharmacology (Berl.)</Emphasis> 2000;148:251–262.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DW</Initials>
                    <FamilyName>Landry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GX-P</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Glickman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM</Initials>
                    <FamilyName>Georgiadis</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Antibody-catalyzed degradation of cocaine</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>259</VolumeID>
                  <FirstPage>1899</FirstPage>
                  <LastPage>1901</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8456315</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.8456315</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXksVSks7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Landry DW, Zhao K, Yang GX-P, Glickman M, Georgiadis TM. Antibody-catalyzed degradation of cocaine.<Emphasis Type="Italic">Science.</Emphasis> 1993;259:1899–1901.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Cashman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Berkman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Underiner</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Catalytic antibodies that hydrolyze (−)-cocaine obtained by a high-throughput procedure</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>293</VolumeID>
                  <FirstPage>952</FirstPage>
                  <LastPage>961</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10869397</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsleksbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cashman JR, Berkman CE, Underiner GE. Catalytic antibodies that hydrolyze (−)-cocaine obtained by a high-throughput procedure.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;293:952–961.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Arakawa-Uramoto</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Anti-cocaine catalytic antibodies: a synthetic approach to improved antibody diversity</ArticleTitle>
                  <JournalTitle>J Am Chem. Soc.</JournalTitle>
                  <VolumeID>118</VolumeID>
                  <FirstPage>5880</FirstPage>
                  <LastPage>5890</LastPage>
                </BibArticle>
                <BibUnstructured>Yang G, Chun J, Arakawa-Uramoto H, et al. Anti-cocaine catalytic antibodies: a synthetic approach to improved antibody diversity.<Emphasis Type="Italic">J Am Chem. Soc.</Emphasis> 1996;118:5880–5890.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Baird</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S-X</Initials>
                    <FamilyName>Deng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DW</Initials>
                    <FamilyName>Landry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Winger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>295</VolumeID>
                  <FirstPage>1127</FirstPage>
                  <LastPage>1134</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11082449</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXosVKisLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baird TJ, Deng S-X, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2000;295:1127–1134.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Matsushita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TZ</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Ashley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cocaine catalytic antibodies: the primary importance of linker effects</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>87</FirstPage>
                  <LastPage>90</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11206477</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(00)00659-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXotlKntg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Matsushita M, Hoffman TZ, Ashley JA, Zhou B, Wirsching P, Janda KD. Cocaine catalytic antibodies: the primary importance of linker effects.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2001;11:87–90.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Isomura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TZ</Initials>
                    <FamilyName>Hoffman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Synthesis, properties, and reactivity of cocaine benzoylthioester possessing the cocaine absolute configuration</ArticleTitle>
                  <JournalTitle>J Am Chem Soc.</JournalTitle>
                  <VolumeID>124</VolumeID>
                  <FirstPage>3661</FirstPage>
                  <LastPage>3668</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11929256</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ja012376y</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhvVaksL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Isomura S., Hoffman TZ, Wirsching P, Janda KD. Synthesis, properties, and reactivity of cocaine benzoylthioester possessing the cocaine absolute configuration.<Emphasis Type="Italic">J Am Chem Soc.</Emphasis> 2002;124:3661–3668.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Meijler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Matsushita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Development of immunopharmacotherapy against drugs of abuse</ArticleTitle>
                  <JournalTitle>Curr Drug Discov Tech.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>77</FirstPage>
                  <LastPage>89</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1570163043484851</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjsVKjuro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Meijler MM, Matsushita M, Wirsching P, Janda KD. Development of immunopharmacotherapy against drugs of abuse.<Emphasis Type="Italic">Curr Drug Discov Tech.</Emphasis> 2004;1:77–89.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Haney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Kosten</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Therapeutic vaccines for substance dependence</ArticleTitle>
                  <JournalTitle>Expert Rev Vaccines.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>11</FirstPage>
                  <LastPage>18</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14761239</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1586/14760584.3.1.11</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXitVClsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Haney M, Kosten TR. Therapeutic vaccines for substance dependence.<Emphasis Type="Italic">Expert Rev Vaccines.</Emphasis> 2004;3:11–18.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Gorelick</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend.</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>159</FirstPage>
                  <LastPage>165</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9449014</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0376-8716(97)00119-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnvVWjs7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gorelick DA. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.<Emphasis Type="Italic">Drug Alcohol Depend.</Emphasis> 1997;48:159–165.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Mattes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Belendiuk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Lynch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RO</Initials>
                    <FamilyName>Brady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Dretchen</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Butyrylcholinesterase: an enzyme antidote for cocaine intoxication</ArticleTitle>
                  <JournalTitle>Addict Biol.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>171</FirstPage>
                  <LastPage>188</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/13556219872236</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjsVWit7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mattes CE, Belendiuk GW, Lynch TJ, Brady RO, Dretchen KL. Butyrylcholinesterase: an enzyme antidote for cocaine intoxication.<Emphasis Type="Italic">Addict Biol.</Emphasis> 1998;3:171–188.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Nachon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Nicolet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Viquie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Masson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Fontecilla-Camps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Lockridge</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization</ArticleTitle>
                  <JournalTitle>Eur J Biochem.</JournalTitle>
                  <VolumeID>269</VolumeID>
                  <FirstPage>630</FirstPage>
                  <LastPage>637</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11856322</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.0014-2956.2001.02692.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhtVygsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nachon F, Nicolet Y, Viquie N, Masson P, Fontecilla-Camps JD, Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.<Emphasis Type="Italic">Eur J Biochem.</Emphasis> 2002;269:630–637.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Mattes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Lynch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Singh</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Therapeutic use of butyrylcholinesterase for cocaine intoxication</ArticleTitle>
                  <JournalTitle>Toxicol Appl Pharmacol.</JournalTitle>
                  <VolumeID>145</VolumeID>
                  <FirstPage>372</FirstPage>
                  <LastPage>380</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9266811</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/taap.1997.8188</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXltlWqsb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mattes CE, Lynch TJ, Singh A, et al. Therapeutic use of butyrylcholinesterase for cocaine intoxication.<Emphasis Type="Italic">Toxicol Appl Pharmacol.</Emphasis> 1997;145:372–380.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Sun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y-P</Initials>
                    <FamilyName>Pang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Lockridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Brimijoin</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Re-engineering butyrylcholinesterase as a cocaine hydrolase</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>220</FirstPage>
                  <LastPage>224</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12130672</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.62.2.220</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlslOrsr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sun H, Pang Y-P, Lockridge O, Brimijoin S. Re-engineering butyrylcholinesterase as a cocaine hydrolase.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2002;62:220–224.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Larocca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Burg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Jensen-Pergakes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PE</Initials>
                    <FamilyName>Ravey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Gonzales</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Baird</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Evolving phage vectors for cell targeted gene delivery</ArticleTitle>
                  <JournalTitle>Curr Pharm Biotechnol.</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>45</FirstPage>
                  <LastPage>57</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11883506</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1389201023378490</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhslOktb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Larocca D, Burg MA, Jensen-Pergakes K, Ravey PE, Gonzales AM, Baird A. Evolving phage vectors for cell targeted gene delivery.<Emphasis Type="Italic">Curr Pharm Biotechnol.</Emphasis> 2002;3:45–57.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GP</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">Filamentous fusion phage, novel expression vectors that display cloned antigens on the virion surface</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>228</VolumeID>
                  <FirstPage>1315</FirstPage>
                  <LastPage>1317</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4001944</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.4001944</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2M3hvVOquw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith GP. Filamentous fusion phage, novel expression vectors that display cloned antigens on the virion surface.<Emphasis Type="Italic">Science.</Emphasis> 1985;228:1315–1317.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Carlton</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Phage therapy: past history and future prospects</ArticleTitle>
                  <JournalTitle>Arch Immunol Ther Exp (Warsz).</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>267</FirstPage>
                  <LastPage>274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10604231</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c%2FmslOhsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carlton RM. Phage therapy: past history and future prospects.<Emphasis Type="Italic">Arch Immunol Ther Exp (Warsz).</Emphasis> 1999;47:267–274.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HW</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Huggins</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Successful treatment of experimental E coli infections in mice using phage: it general superiority over antibiotics</ArticleTitle>
                  <JournalTitle>J Gen Microbiol.</JournalTitle>
                  <VolumeID>128</VolumeID>
                  <FirstPage>307</FirstPage>
                  <LastPage>318</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7042903</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL387ptFGluw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith HW, Huggins RB. Successful treatment of experimental E coli infections in mice using phage: it general superiority over antibiotics.<Emphasis Type="Italic">J Gen Microbiol.</Emphasis> 1982;128:307–318.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Slopek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Weber-Dabrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dabrowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kucharewicz-Krukowski</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Results in bacteriophage treatment of suppurative bacterial infections in the years 1981–1986</ArticleTitle>
                  <JournalTitle>Arch Immunol Ther Exp (Warsz).</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>569</FirstPage>
                  <LastPage>583</LastPage>
                </BibArticle>
                <BibUnstructured>Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowski A. Results in bacteriophage treatment of suppurative bacterial infections in the years 1981–1986.<Emphasis Type="Italic">Arch Immunol Ther Exp (Warsz).</Emphasis> 1986;35:569–583.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Stone</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Stalin’s forgotten cure</ArticleTitle>
                  <JournalTitle>Science.</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>728</FirstPage>
                  <LastPage>731</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12399562</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.298.5594.728</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xot1SmsLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stone R. Stalin’s forgotten cure.<Emphasis Type="Italic">Science.</Emphasis> 2002;298:728–731.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pasqualini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Ruoslahti</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Organ targeting in vivo using phage display peptide libraries</ArticleTitle>
                  <JournalTitle>Nature.</JournalTitle>
                  <VolumeID>380</VolumeID>
                  <FirstPage>364</FirstPage>
                  <LastPage>366</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8598934</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/380364a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvFyrtLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries.<Emphasis Type="Italic">Nature.</Emphasis> 1996;380:364–366.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Essler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Ruoslahti</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculatures</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>2252</FirstPage>
                  <LastPage>2257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11854520</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.251687998</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitVSrtb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Essler M, Ruoslahti E.. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculatures.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:2252–2257.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Dabrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Switala-Jelen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Opolski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Weber-Dabrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gorski</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Bacteriophage penetration in vertebrates</ArticleTitle>
                  <JournalTitle>J Appl Microbiol.</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>7</FirstPage>
                  <LastPage>13</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15610412</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1365-2672.2004.02422.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2cnjsFSmtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dabrowska K., Switala-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A. Bacteriophage penetration in vertebrates.<Emphasis Type="Italic">J Appl Microbiol.</Emphasis> 2005;98:7–13.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Frenkel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Solomon</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Filamentous phage as vector-mediated antibody delivery to the brain</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>5675</FirstPage>
                  <LastPage>5679</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11960022</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.072027199</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjtFKltbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Frenkel D, Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:5675–5679.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C-HL</Initials>
                    <FamilyName>Lo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Lerner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>6025</FirstPage>
                  <LastPage>6030</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10339535</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.96.11.6025</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXksFKlu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gao C, Mao S, Lo C-HL, Wirsching P, Lerner RA, Janda KD. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1999;96:6025–6030.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Gao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kaufmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wirsching</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Lerner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A method for the generation of combinatorial antibody libraries using pIX phage display</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>12612</FirstPage>
                  <LastPage>12616</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12239343</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.192467999</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XnvFGiu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gao C, Mao S, Kaufmann G, Wirsching P, Lerner RA, Janda KD. A method for the generation of combinatorial antibody libraries using pIX phage display.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2002;99:12612–12616.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MRA</Initials>
                    <FamilyName>Carrera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Kaufmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Mee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Meijler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Koob</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Treating cocaine addiction with viruses</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>101</VolumeID>
                  <FirstPage>10416</FirstPage>
                  <LastPage>10421</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15226496</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0403795101</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtVyrs7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carrera MRA, Kaufmann GF, Mee JM, Meijler MM, Koob GF, Janda KD. Treating cocaine addiction with viruses.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 2004;101:10416–10421.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>CF</Initials>
                    <FamilyName>Barbas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Burton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>Scott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Silverman</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <BookTitle>Phage Display: A Laboratory Manual</BookTitle>
                  <PublisherName>Cold Spring Harbor Laboratory Press</PublisherName>
                  <PublisherLocation>Tuebingen, Germany</PublisherLocation>
                </BibBook>
                <BibUnstructured>Barbas CF, Burton DR, Scott JK, Silverman GJ.<Emphasis Type="Italic">Phage Display: A Laboratory Manual</Emphasis>: Tuebingen, Germany: Cold Spring Harbor Laboratory Press; 2001.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lyon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Robbins</FamilyName>
                  </BibAuthorName>
                  <Year>1975</Year>
                  <ChapterTitle Language="En">The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects</ChapterTitle>
                  <BibEditorName>
                    <Initials>W</Initials>
                    <FamilyName>Essman</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>L</Initials>
                    <FamilyName>Valzelli</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Current Developments in Psychopharmacology</BookTitle>
                  <PublisherName>Spectrum</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                  <FirstPage>79</FirstPage>
                  <LastPage>163</LastPage>
                </BibChapter>
                <BibUnstructured>Lyon M, Robbins TW. The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L, eds.,<Emphasis Type="Italic">Current Developments in Psychopharmacology</Emphasis>. vol. 4. New York: Spectrum; 1975:79–163.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Illum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SS</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Polymeric lamellar substrate particles for intranasal vaccination</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Res.</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>97</FirstPage>
                  <LastPage>111</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00171-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Illum L, Davis SS. Polymeric lamellar substrate particles for intranasal vaccination.<Emphasis Type="Italic">Adv Drug Deliv Res.</Emphasis> 2001;51:97–111.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The nose and paranasal sinuses physiology and anatomy</ArticleTitle>
                  <JournalTitle>Adv Drug Deliv Rev.</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>5</FirstPage>
                  <LastPage>19</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11516776</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0169-409X(01)00172-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmtV2ntLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jones N. The nose and paranasal sinuses physiology and anatomy.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2001;51:5–19.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Bresler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Rosser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Basran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NC</Initials>
                    <FamilyName>Bruce</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Gene cloning and nucleotide sequencing and properties of a cocaine esterase from<Emphasis Type="Italic">Rhodococcus</Emphasis> sp strain MB1</ArticleTitle>
                  <JournalTitle>Appl Environ Microbiol.</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>904</FirstPage>
                  <LastPage>908</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10698749</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/AEM.66.3.904-908.2000</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhsFyrtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bresler MM, Rosser SJ, Basran A, Bruce NC. Gene cloning and nucleotide sequencing and properties of a cocaine esterase from<Emphasis Type="Italic">Rhodococcus</Emphasis> sp strain MB1.<Emphasis Type="Italic">Appl Environ Microbiol.</Emphasis> 2000;66:904–908.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
